Up­dat­ed: US puts hold on F-star's takeover by Chi­na’s Sino Bio­pharm, cit­ing na­tion­al se­cu­ri­ty risks

3 years ago
Deals
China

News wrap: Equi­l­li­um ax­es Metacrine merg­er; Two phar­mas pen ADC deals

3 years ago
News Briefing

FDA grants ap­peal for Arde­lyx chron­ic kid­ney dis­ease drug af­ter Ju­ly 2021 re­jec­tion

3 years ago
R&D
FDA+

Pfiz­er re­leas­es he­mo­phil­ia B PhI­II da­ta in chal­lenge to CSL's Hem­genix

3 years ago
R&D

Scoop: To fund Covid-19 nasal vac­cine boost­er, Yale spin­out snags Se­ries A

3 years ago
Financing
Startups

Ever­est Med­i­cines be­gins pro­duc­tion at its new $129M+ mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Chi­na

3 years ago
Coronavirus
Manufacturing

With fo­cus on ne­glect­ed eye dis­eases, Opus buys two gene ther­a­pies from Iver­ic Bio

3 years ago
Startups
Deals

Gilead buys out cash-hun­gry part­ner Jounce's an­ti­body for $67M

3 years ago
Deals

FDA is­sues warn­ing let­ter to South Amer­i­can in­gre­di­ent man­u­fac­tur­er over da­ta prob­lems

3 years ago
FDA+
Manufacturing

Ac­er, Re­lief win FDA ap­proval for rare meta­bol­ic dis­ease af­ter clear­ing in­spec­tion hur­dles

3 years ago
Pharma
FDA+

FDA re­jects Ipsen rare-dis­ease drug, more da­ta and time need­ed to re­view

3 years ago
R&D
FDA+

Up­dat­ed: FDA clears first CD20xCD3 bis­pe­cif­ic, giv­ing Genen­tech leg up in a crowd­ed lym­phoma R&D field

3 years ago
R&D
Pharma

FDA qui­et­ly turns Keytru­da ac­cel­er­at­ed ap­proval for less-fre­quent dos­ing in­to full ap­proval

3 years ago
Pharma
FDA+

Decades of di­ver­si­ty ini­tia­tives lat­er, cer­tain groups re­main 'con­sis­tent­ly un­der­rep­re­sent­ed' in can­cer tri­als, GAO ...

3 years ago
Pharma

Roche's Actem­ra wins ap­proval for hos­pi­tal­ized Covid pa­tients

3 years ago
Pharma
FDA+

Man­u­fac­tur­ing roundup: As­traZeneca widens part­ner­ship in Abu Dhabi; Mod­er­na fi­nal­izes its part­ner­ship with the UK

3 years ago
Manufacturing

Start­up mak­ing soft­ware for phar­ma man­u­fac­tur­ing in­dus­try nets $12M+ Se­ries A

3 years ago
Financing
Startups

Stifel Fi­nan­cial swal­lows life sci­ences in­vest­ment bank Tor­reya Part­ners

3 years ago
Deals

Lex­i­con Phar­ma­ceu­ti­cals an­nounces mid-stage pain fail, blames dos­ing choice

3 years ago
R&D

Gilead wins ap­proval for long-act­ing HIV in­jec­tion af­ter re­solv­ing vial con­cerns

3 years ago
FDA+

Mor­phoSys CFO Sung Lee ex­its as shares suf­fer in mar­ket melt­down

3 years ago
R&D

Vax­cyte makes deal with Sutro Bio­phar­ma to take over man­u­fac­tur­ing of vac­cine com­po­nent

3 years ago
Deals
Manufacturing

Vista­gen ac­quires Pherin Phar­ma­ceu­ti­cals for 12.4M shares and 'nom­i­nal' cash

3 years ago
Deals

Up­dat­ed: ICER on Alzheimer's: lecanemab should be priced low­er than Aduhelm

3 years ago
Pharma
First page Previous page 409410411412413414415 Next page Last page
A service from the Financial Times